🇺🇸 FDA
Patent

US 6667036

Methods of treatment using antibodies to P-selectin glycoprotein ligand

expired A61KA61K2039/505A61K38/00

Quick answer

US patent 6667036 (Methods of treatment using antibodies to P-selectin glycoprotein ligand) held by The Board of Regents of the University of Oklahoma expires Mon Dec 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Dec 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/505, A61K38/00